Point72 Middle East FZE’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,500
Closed -$31.5K 448
2023
Q4
$31.5K Buy
+18,500
New +$31.5K ﹤0.01% 785
2023
Q3
Sell
-67,821
Closed -$78.7K 1124
2023
Q2
$78.7K Buy
+67,821
New +$78.7K ﹤0.01% 722
2023
Q1
Sell
-14,878
Closed -$37.2K 1315
2022
Q4
$37.2K Buy
+14,878
New +$37.2K ﹤0.01% 982